Synopsis of recent research by authors named "Shu Dai"
- Shu Dai's recent research focuses on the pharmacological effects of natural compounds, such as Kaempferol, Luteolin, and Forsythiaside A, to treat various metabolic and liver diseases, underscoring their therapeutic potential and mechanisms of action.
- The use of advanced methodologies like LC-MS/MS, metabolomics, and network pharmacology in studies is aimed at understanding the pharmacokinetics, protective effects, and underlying biological pathways of compounds in contexts such as metabolic disorders, acute lung injury, and liver damage.
- Dai's work also emphasizes the importance of comparative studies, including pharmacokinetics in different disease models, and explores prognostic factors in cancer research, particularly with immune-inflammation indices in oral squamous cell carcinoma.
